Simultaneous Determination of Halobetasol and Salicylic Acid Related Substances by Reversed Phase High Performance Liquid Chromatographic Method

Similar documents
Key Words: Halobetasol, Fusidic acid, RP-HPLC.

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

To develop a simultaneous related substances determination method. for Halobetasol propionate and Fusidic acid in cream formulation and

Ankit et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), Available online at RESEARCH ARTICLE

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

Pelagia Research Library

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

Isocratic Reversed Phase Liquid Chromatographic Method Validation for the Determination of Cilostazol in Pure and Formulations

(ACE) inhibitor class that is primarily used in cardiovascular. conditions. Lisinopril was introduced into therapy in the early

Journal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article

International Journal of Pharma and Bio Sciences

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

CHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG

Journal of Chemical and Pharmaceutical Research

Asian Journal of Chemistry Vol. 21, No. 1 (2009),

Volume 2 (6), 2014, Page CODEN (USA)-IJPRUR, e-issn: International Journal of Pharma Research and Health Sciences

Development and validation of related substances method for Varenicline and its impurities

VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DEXAMETHASONE AND GRANISETRON IN COMBINED DOSAGE FORMS

Simultaneous Estimation of Halobetasol Propionate and Salicylic Acid by RP- HPLC Method

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms

Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

A stability indicating RP-HPLC method for simultaneous estimation of darunavir and cobicistat in bulk and tablet dosage form

Sujatha and Pavani et.al. Indian Journal of Research in Pharmacy and Biotechnology ISSN: (Print) ISSN: (Online)

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

Development and Validation of a Simultaneous HPLC Method for Quantification of Amlodipine Besylate and Metoprolol Tartrate in Tablets

Rao and Gowrisankar: Stability-indicating RP-HPLC Method for Pseudoephedrine, Ambroxol and Desloratadine

Development and Validation of a Polysorbate 20 Assay in a Therapeutic Antibody Formulation by RP-HPLC and Charged Aerosol Detector (CAD)

Comparison of conventional HPLC with UPLC method for determination of albuterol sulfate and it s impurities in pharmaceutical formulation

Journal of Chemical and Pharmaceutical Research

Dhull Rohit, Kumar Sanjay, Jalwal Pawan Department of Chemistry, OPJS Churu, Rajasthan, India

NOVEL RP-HPLC METHOD. B.Lakshmi et a. concentration range KEY INTRODUCTION. Diltiazem is used to. . It works by of contractionn of the. (dilate).

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Available online Research Article

Stress Degradation Studies And Validation Method For Quantification Of Aprepitent In Formulations By Using RP-HPLC

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

Tentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40

A simple validated RP-HPLC method for quantification of sumatriptan succinate in bulk and pharmaceutical dosage form

Journal of Pharmacreations

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF TRAMADOL IN PURE AND PHARMACEUTICAL FORMULATIONS

ANALYTICAL TECHNIQUES FOR THE QUALITY OF ANTI- AIDS DRUGS

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Research Article Simultaneous Estimation of DL-Methionine and Pyridoxine Hydrochloride in Tablet Dosage Form by RP-HPLC

ISSN (Print)

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

New RP-HPLC Method for the Determination of Fludarabine in Pharmaceutical Dosage Forms

Sanjog Ramdharane 1, Dr. Vinay Gaitonde 2

Method Development and Validation for the Estimation of Saroglitazar in Bulk and Pharmaceutical Dosage Form by RP-HPLC

J Pharm Sci Bioscientific Res (4): ISSN NO

IJRPC 2013, 3(2) Nagamallika et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

DETERMINATION OF LOTEPREDNOL ETABONATE AND TOBRAMYCIN IN COMBINED DOSAGE FORM USING RP-HPLC METHOD

A Validated Stability Indicating RP-HPLC Method for Simultaneous Estimation of Valsartan and Clinidipine Combined Tablet dosage forms

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

CHAPTER-5. Sumatriptan Succinate

Development and validation of RP-HPLC method for simultaneous estimation of gliclazide and metformin in pure and tablet dosage form

Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Haloperidol and Trihexyphenidyl in API and Combined Tablet Dosage Form

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

Bendre S.D. & Ghule P.J. Int. Res. J. Pharm. 2016, 7 (12) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

Airo International Research Journal ISSN : Volume : 7 October 2015

Estimation of Emtricitabine in Tablet Dosage Form by RP-HPLC

36 J App Pharm Vol. 6; Issue 1: 36-42; January, 2014 Rao et al., 2014

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ASSAY AND DISSOLUTION OF METOPROLOL SUCCINATE EXTENDED RELEASE TABLETS

Stability indicating RP-HPLC method for simultaneous determination of Beclomethasone Dipropionate and Clotrimazole from dosage form

International Journal of Drug Research and Technology

Volume 6, Issue 1, January February 2011; Article-021

Pankti M. Shah et al, Asian Journal of Pharmaceutical Technology & Innovation, 04 (17); 2016; 07-16

Corresponding Author:

World Journal of Pharmaceutical Research

International Journal of Applied Pharmaceutical Sciences and Research

Available Online through (or) IJPBS Volume 2 Issue 4 OCT-DEC Research Article Pharmaceutical Sciences

S. G. Talele, D. V. Derle. Department of Pharmaceutics, N.D.M.V.P. College of Pharmacy, Nashik, Maharashtra, India

Estimation of zolmitriptan by a new RP-HPLC method

AMERICAN JOURNAL OF BIOLOGICAL AND PHARMACEUTICAL RESEARCH

Method Development and Validation for Simultaneous Estimation of Atorvastatin and Ezetimibe in Pharmaceutical Dosage Form by HPLC

Amudha S et al., Asian Journal of Pharmthiaceutical Technology & Innovation, 04 (21); 2016; Research Article

SIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD

Determination of Dapiprazole Hydrochloride in the Presence of Process and Degradation Impurities by a Validated Stability Indicating RP-HPLC Method

Stability indicating RP-HPLC method development and validation of Etizolam and Propranolol hydrochloride in pharmaceutical dosage form

Method Validation for Simultaneous Estimation of Prednisolone and Abiraterone Acetate by RP-HPLC

Simultaneous For the Estimation of Metformin and Empagliflozin in Pharmaceutical Dosage Form by HPLC Method

DETERMINATION OF OXYCODONE CONTENT AND RELATED SUBSTANCES IN OXYCODONE AND ACETAMINOPHEN CAPSULE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

F. Al-Rimawi* Faculty of Science and Technology, Al-Quds University, P.O. Box 20002, East Jerusalem. Abstract

Scholars Research Library. Der Pharmacia Lettre, 2016, 8 (6): (

A Reverse Phase HPLC Method Development and Validation for the Determination of Paliperidone in Pure and Dosage Forms

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

International Journal of Applied Pharmaceutical Sciences and Research

Department of Pharmaceutical Analysis, Joginpally B.R. Pharmacy College, Yenkapally, Moinabad, R.R. Dist, A.P, India

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ETORICOXIB AND THIOCOLCHICOSIDE IN PHARMACEUTICAL DOSAGE FORMS

Available online at Scholars Research Library

Mohammed and Rudwan, IJPSR, 2016; Vol. 7(6): E-ISSN: ; P-ISSN:

Transcription:

Asian Journal of Chemistry Vol. 22, No. 5 (2010), 3369-3375 Simultaneous Determination of Halobetasol and Salicylic Acid Related Substances by Reversed Phase High Performance Liquid Chromatographic Method R. ANKAM*, K. MUKKANTI, S. DURGAPRASAD and P.V.L. NAIDU Glenmark Pharmaceuticals Ltd., R and D Centre, Plot No. C-152, M.I.D.C., Malegaon-422 113, India E-mail: ankam_1999@yahoo.com A simple fast, accurate, precise and cost effective reverse phase high performance liquid chromatographic method is developed for simultaneous determination of halobetasol propionate and salicylic acid impurities in the ointment formulation. The chromatography equipped with inertsil C-8 (250 mm 4.6 mm) column using a mobile phase of buffer (0.1 % of orthophosphoric acid) and acetonitrile with a flow rate of 1.5 ml/min, with ultraviolet detector configured at 231 nm. The method is found to be linear in the range of 0.118-17.734 for 4-hydroxy benzoic acid, 0.120-9.036 for 4-hydroxy isophthalic acid, 0.12-3.586 for phenol, 0.103-8.987 for salicylic acid, 0.069-1.480 for diflorasone 21 propionate, 0.071-1.472 for diflorasone 17 propionate 21 mesylate and 0.057-1.514 for halobetasol propionate. Key Words: Halobetasol, Salicylic acid, RP-HPLC. INTRODUCTION Halobetasol propionate 1 (1) chemically is 2-chloro-6α,9-difluoro-11β,17-dihydroxy- 16β-methylpregna-1,4-diene-3,20-dione-17-propionate. It is a superior high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatitis. (1) Halobetasol propionate Salicylic acid is a β-hydroxy acid with the formulae C 6 H 4 (OH)CO 2 H, widely used in organic synthesis and function as a plant hormone 2,3. It is derived from the Centre for Environment IPGSR, JNT University, Hyderabad-500 028, India. Indian Immunologicals Ltd., Rakshapuram, Gachibowli, Hyderabad-500 019, India.

3370 Ankam et al. Asian J. Chem. metabolism of salicylin. It is probably best known as compound that is chemically similar to but not identical to the active component of aspirin (acetylsalicylic acid) in fact salicylic acid is a metabolite of aspirin, the product of esterase hydrolysis in the liver. Salicylic acid is a keratolytic (peeling agent) it will destroy all type of skin cells 4. Salicylic acid causes shelding of the outer layer of skin and it is used in the treatment of acne, dandruff, corns and warts 4. EXPERIMENTAL Orthophosphoric acid, acetonitrile, methanol, all HPLC grade were purchased from Merck. Chromatographic conditions: Column: Inertsil, C-8, 250 mm 4.6 mm, 5 µ; Wavelength: 231 nm; Flow rate: 1.5 ml/min gradient; Injection volume: 50 µl; Column temperature: 40 ºC; Run time: 40 min. Retention time: 4-Hydroxy benzoic acid: 3.1 min; 4-Hydroxy isophthalic acid: 4.6 min; : 5.0 min; Salicylic acid: 8.3 min; Diflorasone 21 propionate: 20.2 min; Diflorasone 17 propionate 21 mesylate: 22.7 min; Halobetasol propionate: 23.9 min. Buffer solution: 1 ml orthophosphoric acid added to 1000 ml of water, mixed and filtered through 0.45 µ filter. Diluent: Mixed water, acetonitrile and methanol in the ratio of 65:25:10 (v/v) and filtered through 0.45 µ filter. Preparation of stock solutions: Prepared each solution separately having the concentration of 4-hydroxy benzoic acid 600 ppm, 4-hydroxy isophthalic acid 300 ppm, phenol 120 ppm, salicylic acid 300 ppm, diflorasone-21-propionate 10 ppm, diflorasone-17-propionate-21 mesylate 10 ppm, halobetasol propionate 10 ppm. Mixed standard solution: To a volumetric flask, added 10 ml of halobetasol propionate and its related compounds and 2 ml of each 4-hydroxy benzoic acid, 4- hydroxy isophthalic acid, phenol, salicylic acid and make up to volume with diluent. (Concentration of 4-hydroxy benzoic acid 12 ppm, 4-hydroxy isophthalic acid 6 ppm, phenol 2.4 ppm, salicylic acid 6 ppm, diflorasone-21-propionate 1 ppm, diflorasone-17-propionate-21 mesylate 1 ppm, halobetasol propionate 1 ppm). Placebo preparation: Place 5 g of placebo in a 50 ml volumetric flask, added 25 ml of diluent and kept on water bath at 80 ºC for 15-20 min and cooled to room temperature. Mixed the solution well and chilled the sample in ice bath and filtered through 0.45 µ Teflon filter. Sample preparation: Place 5 g of sample in a 50 ml volumetric flask, added 25 ml of diluent and kept on water bath at 80 ºC for 15-20 min and cooled to room temperature. Mixed the solution well and chilled the sample in ice bath and filtered through 0.45 µ Teflon filter. Procedure for injection: Injected equal volumes of diluent, placebo preparation, standard preparation in 6 replicates separately and sample once in equilibrated HPLC system and recorded the chromatograms and measured the response in terms of peak area.

Vol. 22, No. 5 (2010) RP-HPLC Determination of Halobetasol & Salicylic Acid Related Substances 3371 RESULTS AND DISCUSSION Specificity: The sample and standard are subjected for forced degradation and the % impurities generated are calculated and reported values were given in Tables 1 and 2. TABLE-1 FORCED DEGRADATION OF SALICYLIC ACID IN THE SAMPLE Name of impurity 4-Hydroxy 4-Hydroxy Impurity at Impurity at benzoic acid isophthalic acid RRT 1.4 RRT 1.54 % Degradation Peroxide degradation 0.006 0.002 0.00 0.011 0.003 Acid degradation 0.000 0.008 0.00 0.013 0.005 Base degradation 0.007 0.000 0.00 0.00 0.000 Thermal degradation 0.000 0.000 0.00 0.011 0.003 Photo degradation 0.000 0.000 0.00 0.011 0.003 Humidity degradation 0.000 0.000 0.00 0.011 0.003 TABLE-2 FORCED DEGRADATION OF HALOBETASOL PROPIONATE IN THE SAMPLE Name of impurity Diflorasone 21 propionate Diflorasone 17 propionate 21 mesylate Impurity at RRT 1.02 Peroxide degradation 0.575 0.00.0.184 Acid degradation 0.392 0.00 1.789 Base degradation 22.03 0.00 0.00 Thermal degradation 0.091 0.00 0.186 Photo degradation 0.080 0.00 0.182 Humidity degradation 0.086 0.00 0.177 Accuracy: Accuracy was studied at four concentration level at LOQ level, 50 % level, 100 % level and 150 % level of working concentration. Each level was studied in triplicate. Each preparation was prepared independently by spiking analyte in the placebo. Per cent recovery was calculated by comparing response obtained in spiked sample with those obtained in standard and obtained results are given in Table-3. Precision: To demonstrate intermediate precision (ruggedness) of the method by comparing method precision (in terms of absolute difference) on two different days carried out by different analyst. System precision: System suitability standard solution was analyzed in six replicates using test procedure under validation. Responses obtained due to impurity peak in each replicate of system suitability standard solution were recorded. % RSD for the response is calculated and obtained results are given in Table-4. Method precision (repeatability): Six sample solutions will be prepared as described in methodology for impurities ointment. Calculate the % impurities, mean and % RSD for impurities and obtained results are given in Table-5.

3372 Ankam et al. Asian J. Chem. Name of impurity TABLE-3 TOTAL ALL KNOWN IMPURITIES RECOVERY 4-Hydroxy benzoic acid 4-Hydroxy isophthalic acid Diflorasone 21 propionate Diflorasone 17 propionate 21 mesylate % Recovery Level-LOQ spl-1 104.9 97.3 103.5 97.0 104.4 Level-LOQ spl-2 96.7 96.8 101.2 92.0 95.0 Level-LOQ spl-3 103.6 95.5 103.9 96.4 101.1 Mean 101.7 96.5 102.9 95.1 100.2 S.D 4.4 0.92 1.45 2.73 4.76 %RSD 4.33 0.96 1.41 2.87 4.76 Level-50 spl-1 101.5 105.4 101.4 100.0 93.9 Level-50 spl-2 102.0 105.7 101.1 100.8 94.8 Level-50 spl-3 101.8 105.3 101.6 100.0 93.9 Level-100 spl-1 98.3 99.4 96.0 100.4 97.8 Level-100 spl-2 98.0 98.8 95.6 99.6 97.0 Level-100 spl-3 97.8 98.3 95.9 99.2 96.1 Level-150 spl-1 98.0 98.2 97.6 98.7 98.0 Level-150 spl-2 97.9 98.2 97.3 98.7 98.0 Level-150 spl-3 98.1 98.3 97.3 98.9 98.3 Mean 99.3 100.8 98.2 99.6 96.4 S.D. 1.88 3.48 2.47 0.76 1.81 % RSD 1.89 3.46 2.52 0.76 1.87 TABLE-4 PRECISION DATA OF SALICYLIC ACID, HALOBETASOL PROPIONATE AND RELATED SUBSTANCES 4-Hydroxy 4-Hydroxy Halobetasol Salicylic acid benzoic acid isophthalic acid propionate Replicate-1 589795 879152 20656 589104 62117 Replicate-2 589866 880867 20977 589789 62431 Replicate-3 590643 881337 21399 590351 62111 Replicate-4 592426 885240 21436 590325 62819 Replicate-5 589396 873347 19845 588328 62779 Replicate-6 590293 874352 21215 588468 62453 Mean 590403 879049 20921 589394 62452 S.D 1080.21 4504.53 601.88 896.28 306.78 % RSD 0.1800 0.5100 2.8800 0.1500 0.4900 % RSD for impurities free base peak response in standard solution is maximum 2.88 % for phenol, which is well within the acceptance criteria not more than 5.0 %. % RSD also obtained for impurities is 5.83 % for the six determinations and is well within the acceptance criteria NMT 10.0 % (Table-6).

Vol. 22, No. 5 (2010) RP-HPLC Determination of Halobetasol & Salicylic Acid Related Substances 3373 TABLE-5 PRECISION DATA OF TOTAL IMPURITIES Name of Diflorasone 21 Diflorasone 17 Impurity at RRT impurity propionate propionate 21 mesylate 1.02 Total impurities Precision set-1 1.002 0.964 0.185 2.151 Precision set-2 1.007 0.944 0.159 2.11 Precision set-3 1.007 0.942 0.174 2.123 Precision set-4 0.991 0.937 0.171 2.099 Precision set-5 0.987 0.939 0.159 2.085 Precision set-6 0.989 0.939 0.173 2.101 Average 0.997 0.944 0.170 2.112 S.D 0.009 0.010 0.010 0.023 % RSD 0.924 1.062 5.834 1.093 TABLE-6 INTERMEDIATE PRECISION DATA OF SALICYLIC ACID, HALOBETASOL PROPIONATE, RELATED SUBSTANCES AND IMPURITIES 4 Hydroxy 4 Hydroxy Salicylic Halobetasol Total benzoic acid isophthalic acid acid propionate impurities Replicate-1 0.197 0.100 0.040 0.012 0.003 0.352 Replicate-2 0.196 0.100 0.040 0.012 0.003 0.351 Replicate-3 0.195 0.100 0.039 0.012 0.003 0.349 Replicate-4 0.194 0.099 0.040 0.012 0.003 0.348 Replicate-5 0.194 0.099 0.039 0.012 0.003 0.347 Replicate-6 0.194 0.099 0.039 0.012 0.003 0.347 MEAN 0.195 0.100 0.040 0.012 0.003 0.349 S.D 0.000 0.000 0.000 0.000 0.000 0.000 % RSD 0.650 0.550 1.390 0.000 0.000 0.600 Linearity: Linearity is studied over the range of LOQ to 150 % of the test concentration at different levels. Linearity is studied at seven concentration level (LOQ, 50, 80, 90, 100, 110, 120 and 150 % of test concentration). A graph of concentration vs response was plotted. Correlation coefficient, slope, intercept were calculated (Tables 7-9). TABLE-7 LIMIT OF DETECTION (LOD) AND LIMIT OF QUANTIFICATION (LOQ) IN Name of compound LOD LOQ 4 Hydroxy benzoic acid 0.036 0.121 4 Hydroxy isophathlic acid 0.036 0.120 0.036 0.120 Salicylic acid 0.031 0.104 Diflorasone 21 propionate 0.070 0.021 Diflorasone 17 propionate 21 mesylate 0.073 0.022 Halobetasol propionate 0.057 0.017

3374 Ankam et al. Asian J. Chem. TABLE-8 LINEARITY OF HALOBETASOL PROPIONATE AND ITS RELATED SUBSTANCES Name of compound Diflorasone 21 Diflorasone 17 Halobetasol propionate propionate propionate 21 mesylate Level-LOQ 0.069 1385 0.071 1153 0.057 1765 Level-50 % 0.493 29856 0.491 26915 0.505 32006 Level-80 % 0.790 47911 0.785 43360 0.807 51200 Level-90 % 0.888 54006 0.883 48813 0.908 57666 Level-100 % 0.987 59164 0.982 53424 1.009 63099 Level-110 % 1.086 65316 1.080 59035 1.110 69477 Level-120 % 1.184 72435 1.178 65376 1.211 77225 Level-150 % 1.480 90432 1.472 81048 1.514 96005 Slope 62672 57001 64395 Intercept 2095-2009 1264 Correlation coefficient 0.9996 0.9996 0.9997 TABLE-9 LINEARITY OF SALICYLIC ACID AND ITS RELATED SUBSTANCES 4-Hydroxy benzoic Name of acid Compound 4-Hydroxy isophthalic acid Salicylic acid Level-LOQ 0.118 6415 0.120 9299 0.120 1606 0.103 6822.0 Level-50 % 5.911 311638 3.012 453251 1.195 14206 2.996 302869 Level-80 % 9.458 498793 4.819 726880 1.912 21961 4.793 485049 Level-90 % 10.64 561784 5.422 817451 2.151 24639 5.392 544673 Level-100 % 11.82 613916 6.024 878306 2.390 26889 5.992 596324 Level-110 % 13.00 678178 6.626 983895 2.629 29841 6.591 655896 Level-120 % 14.18 752253 7.229 1090428 2.868 32859 7.190 726542 Level-150 % 17.73 937076 9.036 1360643 3.586 40512 8.987 906572 Slope 52705 150761 11196 100890 Intercept 989.0 6904 481 2136 Correlation coefficient 0.9998 0.9996 0.9998 0.9998 Solution stability: Sample was spiked with known amount of impurities and the same sample was monitored for stability of different time intervals. The results for % impurities of sample obtained at different pool time are compared with initial % impurities value (Table-10).

Vol. 22, No. 5 (2010) RP-HPLC Determination of Halobetasol & Salicylic Acid Related Substances 3375 TABLE-10 SOLUTION STABILITY OF IMPURITIES Name of 4-Hydroxy 4-Hydroxy Diflorasone-21- Diflorasone-17- impurity benzoic acid isophthalic acid propionate propionate-21-mesylate Initial 0.203 0.106 0.040 1.052 0.956 After 8 h 0.205 0.105 0.040 1.015 0.951 After 12 h 0.205 0.105 0.042 1.039 0.941 Mean 0.204 0.105 0.041 1.035 0.949 S.D 0.001 0.001 0.001 0.019 0.008 % RSD 0.565 0.548 2.830 1.810 0.805 REFERENCES 1. G. Lunn, HPLC Methods for Recently Approved Pharmaceuticals, John Wiley & Sons, pp. 306-315 (2005). 2. T. Kawano and T. Furuichi in eds.: S. Hayat and A. Ahmad, Salicylic Acid: A Plant Hormone, Springer, Netherlands, pp. 277-321 (2007) 3. A. Santner, L.I.A. Calderon-Villalobos and M. Estelle, Nature Chem. Biol.. 5, 301 (2009). 4. M. Ramos-e-Silva and S.C. da Silva Carneiro, Clin. Dermat., 19, 413 (2001). (Received: 27 February 2009; Accepted: 11 January 2010) AJC-8280 3RD INTERNATIONAL CONGRESS ON INFORMATION AND COMMUNICATION TECHNOLOGIES IN AGRICULTURE, FOOD, FORESTRY & ENVIRONMENT (ITAFFE 10) 14 18 JUNE 2010 SAMSUN, TURKEY Contact: Prof. Dr. Zeynel Cebeci Prof. Dr. Mehmet Kuran President of the Congress President of Organizing Committee E-mail: zcebeci@cukurova.edu.tr E-mail : mkuran@omu.edu.tr Tel/Fax: +90 322 3386445 Fax: +90 362 4576034 Tel: +90 322 3386084-2184(Ext) Tel: +90 362 3121919-1124(Ext) Website: http://www.itaffe10.org